Aggregation, Release and Desensitization Induced in Platelets from Five Species by Platelet Activating Factor (PAF)

Summary

PAF-induced aggregation and dense granule release (ATP release) were investigated in human, primate, guinea pig, rabbit and rat platelet-rich plasma (PRP). Guinea pig PRP was most sensitive to PAF, followed by rabbit and then human. PRP from rats and primates did not aggregate or release when exposed to PAF.

In guinea pig and rabbit PRP, release was independent of aggregatory response. In human PRP high doses of PAF (5 × 10^-7M) caused maximum aggregation and a biphasic ATP release, whilst lower concentrations (3×10^-8M) induced biphasic aggregation and one phase of ATP release concomitant with the second phase of aggregation.

Aggregation and ATP release induced by PAF in guinea pig and rabbit PRP is dependent upon Ca⁺⁺ levels, whilst the response of human platelets is relatively independent of the Ca⁺⁺ level above a certain threshold concentration.

The PRP from the three species which aggregated with PAF also demonstrate the phenomenon of desensitization.

Keywords

PAF - Platelet aggregation - Dense granule release - Human, Rat, Guinea pig, Rabbit, Primate PRP

• References

• 1 Benveniste J, Henson PM, Cochrane CG. Leukocyte dependent histamine release from rabbit platelets. The role of IgE, basophils and platelet activating factor. J Exp Med 1972; 136: 1356-1377
• 2 Henson PM. Release of vasoactive amines from platelets induced by sensitized mononuclear leukocytes and antigen. J Exp Med 1970; 131: 287-306
• 3 Demopoulos CA, Pinckard RN, Hanahan DJ. Platelet activating factor evidence for l-0-alkyl-2-acetyl-sn-glyceryl-3-phosphoryl-choline as the active component. J Biol Chem 1979; 254: 9355-9358
• 4 Benveniste J, Tence M, Varenne P, Bidault J, Boullet C, Polonsky J. Semi-synthesis and proposed structure of platelet activating factor (PAF). PAF-acether an alkyl ether analogue of lysophosphatidyl choline. C R Acad Sri (D) (Paris) 1979; 289: 1017-1021
• 5 Benveniste J. Platelet activating factor (PAF). Adv Allerg Immunol. Oehling A. (ed) Pergamon, Oxford: 1980: 195-202
• 6 Pinkard RN, McManus LM, Demopoulos CA, Halonen M, Clarke PO, Shaw JO, Kurker WT, Hanahan DJ. Molecular patbobiology of acetyl glyceryl ether phosphorylcholine. J Retie Soc 1980; 28 Suppl: 95-103
• 7 Camussi G, Aglietta M, Coda R, Bussolino F, Piacihollo W, Tetta C. Release of platelet activating factor (PAF) and histamine. Immunology 1981; 42: 191-199
• 8 McManus LM, Hanahan DJ, Pinkard RN. Human platelet stimulation by acetyl glyceryl ether phosphoryl choline. J Clin Invest 1981; 67: 903-906
• 9 Anderson ER, Foulks JG. Competitive inhibition by lithium and hydrogen ions of the effect of calcium on the aggregation of rabbit platelets. Thromb Haemostas 1976; 36: 343-359
• 10 De PradaM, Richards JG, Kettler R. Amine storage organelles in platelets. In Platelets in Biology and Pathology. Elsevier/North Holland 1981; 02: 107-139
• 11 Taylor PM, Heptinstall S. The ability of human blood platelets to bind extracellular calcium and to be aggregated by adenosine diphosphate are related. Br J Haematol 1980; 46: 115-122
• 12 Henson PM. Activation and desensitization of platelets by platelet activating factor derived from IgE-sensitized basophils. J Exp Med 1976; 143: 937-952
• 13 Vargaftig BB, Lefort J, Chignard M, Benveniste J. Platelet activating factor induces a platelet dependent bronchoconstriction unrelated to the formation of prostaglandin derivatives. Eur J Pharmacol 1980; 65: 185-192
• 14 Lewis JC, O’Flaherty JT, McCall CM, Wykle RL. Endothelial alterations during the platelet activating factor (PAF) respiratory distress syndrome. Thromb Haemostas 1981; 46: 293 (Abstr.).